Reference | CS | Dataset | FS | Time | FN | Acc. | AUC |
---|---|---|---|---|---|---|---|
Our approach | 1 | Leukemia | SNFS with CDD | 71.22 (59.04-83.38)\(^1\) | 8-10 | 88.24-97.06\(^2\) | 93.93-100\(^2\) |
Our approach | 1 | Colon cancer | SNFS with CDD | 37.23 (32.33-83)\(^1\) | 11-12 | 63.16-89.47\(^2\) | 82.14-96.43\(^2\) |
Ozyer et al. [5] | 2 | Leukemia | SNFS | NM | 9 | 97.06 | NM |
Ozyer et al. [5] | 2 | Colon cancer | SNFS | NM | 9 | 100 | NM |
Ding et al. [56] | 3 | Leukemia | OELM-RFE | NM | 4 | 84.38 | NM |
Khaire and Dhanalakshmi [57] | NM | Leukemia | IWOA | NM | NM | 81 | 92 |
Khaire and Dhanalakshmi [57] | NM | Colon cancer | IWOA | NM | NM | 83 | 84 |
Kundu et al. [58] | 4 | Leukemia | AWOA | 41.53 | 30 | 100 | 100 |
Kundu et al. [58] | 4 | Colon cancer | AWOA | 10.37 | 21 | 100 | Approx. 100 |
Vatankhah and Momenzadeh [59] | 5 | Leukemia | Self-regularized LASSO | 14.97 | 1 | NM | 100 |